| Financial Year |
March 31 2023 |
| Monetary Funds |
416,145,016.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
145,044,406.62 |
| Accounts Receivable |
189,518,000.13 |
| Advances to Suppliers |
24,149,707.56 |
| Other Receivables |
158,806,173.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
171,063,882.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,036,941.46 |
| Total Current Assets |
1,152,053,789.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
386,136,180.84 |
| Investment Properties |
-- |
| Fixed Assetes |
973,148,549.27 |
| Under-construction Projects |
115,169,499.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,889,550.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,825,931.05 |
| Deferred Income Tax Assets |
36,901,800.10 |
| Other Non-Current Assets |
170,468,100.17 |
| Sub-Total of Non-Current Assets |
1,755,539,610.88 |
| Total Assets |
2,907,593,400.05 |
| Short-Term Loans |
575,809,337.26 |
| Trading Financial liabilities |
886,500.00 |
| Notes Payable |
158,908,171.80 |
| Accounts Payable |
341,132,969.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,619,550.04 |
| Taxes Payable |
16,229,455.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,183,217.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
134,499,795.39 |
| Sub-Total of Current Liabilities |
1,312,081,174.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,392,020.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,679,030.16 |
| Total Liabilities |
1,336,760,204.24 |
| Paid-In Capital(Or Share Stock) |
986,833,096.00 |
| Capital Surplus |
-245,758,138.53 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
719,276,700.37 |
| Minority Stockholder's Interest |
103,814,215.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,467,018,980.21 |
| Owner's Equity（Stockholder's Equity） |
1,570,833,195.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,907,593,400.05 |
